Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome: A systematic review

Annals of Internal Medicine

Volumn 161, Issue 7, 2014, Pages 502-512

  Stacy, Sylvie R ^a   Suarez Cuervo, Catalina ^b   Berger, Zackary ^a   Wilson, Lisa M ^b   Yeh, Hsin Chieh ^b   Bass, Eric B ^c   Michos, Erin D ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN; TROPONIN I; TROPONIN T; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ADVERSE OUTCOME; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCARDIOGRAPHY; GLOMERULUS FILTRATION RATE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; PROTEIN FUNCTION; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; BLOOD; CARDIOVASCULAR DISEASES; CHRONIC KIDNEY FAILURE; COMPLICATION; RENAL REPLACEMENT THERAPY; RISK;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; PROGNOSIS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK; SENSITIVITY AND SPECIFICITY; TROPONIN I; TROPONIN T;

EID: 84908102129     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-0746     Document Type: Review

References (46)

1. Cannon CP, Brindis RG, Chaitman BR, Cohen DJ, Cross JT Jr, Drozda JP Jr, et al; American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards. 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards). Circulation. 2013;127:1052-89. [PMID: 23357718] doi:10.1161/CIR .0b013e3182831a11
2. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al; American College of Cardiology. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non- ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50:e1-e157. [PMID: 17692738]
3. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581-98. [PMID: 22958960] doi:10.1016/j.jacc. 2012.08.001
4. Jaffe AS. Chasing troponin: how low can you go if you can see the rise? [Editorial]. J Am Coll Cardiol. 2006;48:1763-4. [PMID: 17084246]
5. Newby LK, Jesse RL, Babb JD, Christenson RH, De Fer TM, Diamond GA, et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2012;60:2427-63. [PMID: 23154053] doi: 10.1016/j.jacc.2012.08.969
6. Wu AH, Jaffe AS, Apple FS, Jesse RL, Francis GL, Morrow DA, et al; NACB Writing Group. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem. 2007;53:2086-96. [PMID: 17954494]
7. Needham DM, Shufelt KA, Tomlinson G, Scholey JW, Newton GE. Troponin I and T levels in renal failure patients without acute coronary syndrome: a systematic review of the literature. Can J Cardiol. 2004;20:1212-8. [PMID: 15494773]
8. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation. 2005;112:3088-96. [PMID: 16286604]
9. National Institute of Diabetes and Digestive and Kidney Diseases. United States Renal Data System: 2011 USRDS Annual Data Report. Volume Two: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health; 2011. Accessed at www.usrds.org/2011/pdf/v2-00-intro-11.pdf on 18 July 2014.
10. Khan IA, Wattanasuwan N, Mehta NJ, Tun A, Singh N, Singh HK, et al. Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: a two-year outcome analysis. J Am Coll Cardiol. 2001;38:991-8. [PMID: 11583870]
11. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2011. Accessed at www.cochrane-handbook.org on 18 July 2014.
12. Michos ED, Berger Z, Yeh HC, Suarez-Cuervo C, Wilson LM, Stacy S, et al. Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients with Kidney Disease. Evidence report/technology assessment no. 135. AHRQ publication no. 14-EHC030-EF. (Prepared by the Johns Hopkins University Evidence-based Practice Center under contract 290-2012-00007-I.) Rockville, MD: Agency for Healthcare Research and Quality; 2014.
13. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377-84. [PMID: 9764259]
14. Agency for Healthcare Research and Quality. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. AHRQ publication no. 10(11)- EHC063-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2012.
15. Flores-Solís LM, Hernández-Domínguez JL, Otero-González A, González- Juanatey JR. Cardiac troponin I and creatine kinase MB isoenzyme in patients with chronic renal failure. Nefrologia. 2012;32:809-18. [PMID: 23169364] doi: 10.3265/Nefrologia.pre2012.Jul.10986
16. Flores LM, Hernández Dominguez JL, Otero A, González Juanatey JR. [Cardiac troponin I determination in patients with chronic renal failure]. Nefrologia. 2006;26:107-12. [PMID: 16649431]
17. Fehr T, Knoflach A, Ammann P, Pei P, Binswanger U. Differential use of cardiac troponin T versus I in hemodialysis patients. Clin Nephrol. 2003;59: 35-9. [PMID: 12572929]
18. Apple FS, Christenson RH, Valdes R Jr, Andriak AJ, Berg A, Duh SH, et al. Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. Clin Chem. 1999;45:199-205. [PMID: 9931041]
19. Bhagavan NV, Goldstein AP, Honda SA, Uyehara J, Blaisdell J, Sugiyama C, et al. Role of cardiac troponin I in the evaluation of myocardial injury. J Clin Lab Anal. 1998;12:276-9. [PMID: 9773957]
20. Martin GS, Becker BN, Schulman G. Cardiac troponin-I accurately predicts myocardial injury in renal failure. Nephrol Dial Transplant. 1998;13:1709-12. [PMID: 9681716]
21. Sukonthasarn A, Ponglopisit S. Diagnostic level of cardiac troponin T in patients with chronic renal dysfunction, a pilot study. J Med Assoc Thai. 2007; 90:1749-58. [PMID: 17957915]
22. Alcalai R, Planer D, Culhaoglu A, Osman A, Pollak A, Lotan C. Acute coronary syndrome vs nonspecific troponin elevation: clinical predictors and survival analysis. Arch Intern Med. 2007;167:276-81. [PMID: 17296884]
23. McCullough PA, Nowak RM, Foreback C, Tokarski G, Tomlanovich MC, Khoury NE, et al. Performance of multiple cardiac biomarkers measured in the emergency department in patients with chronic kidney disease and chest pain. Acad Emerg Med. 2002;9:1389-96. [PMID: 12460842]
24. Noeller TP, Meldon SW, Peacock WF, Emerman CL, McErlean ES, Vanlente F, et al. Troponin T in elders with suspected acute coronary syndromes. Am J Emerg Med. 2003;21:293-7. [PMID: 12898485]
25. Chenevier-Gobeaux C, Meune C, Freund Y, Wahbi K, Claessens YE, Doumenc B, et al. Influence of age and renal function on high-sensitivity cardiac troponin T diagnostic accuracy for the diagnosis of acute myocardial infarction. Am J Cardiol. 2013;111:1701-7. [PMID: 23540652] doi:10.1016/j .amjcard.2013.02.024
26. Haaf P, Reichlin T, Twerenbold R, Hoeller R, Rubini Gimenez M, Zellweger C, et al. Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays. Eur Heart J. 2014;35:365-75. [PMID: 23821402] doi:10.1093/eurheartj/eht218
27. Ikeda J, Zenimoto M, Kita M, Mori M. [Usefulness of cardiac troponin I in patients with acute myocardial infarction]. Rinsho Byori. 2002;50:982-6. [PMID: 12451679]
28. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined- a consensus document of The Joint European Society of Cardiology/ American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-69. [PMID: 10987628]
29. Pfortmueller CA, Funk GC, Marti G, Leichtle AB, Fiedler GM, Schwarz C, et al. Diagnostic performance of high-sensitive troponin T in patients with renal insufficiency. Am J Cardiol. 2013;112:1968-72. [PMID: 24091183] doi:10.1016/j.amjcard.2013.08.028
30. Chew HC. Cardiac troponin T in acute coronary syndrome with renal insufficiency. Asian Cardiovasc Thorac Ann. 2008;16:284-7. [PMID: 18670019]
31. Melloni C, Alexander KP, Milford-Beland S, Newby LK, Szczech LA, Pollack CV, et al; Crusade Investigators. Prognostic value of troponins in patients with non-ST-segment elevation acute coronary syndromes and chronic kidney disease. Clin Cardiol. 2008;31:125-9. [PMID: 18383049] doi:10.1002/ clc.20210
32. Aviles RJ, Askari AT, Lindahl B, Wallentin L, Jia G, Ohman EM, et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med. 2002;346:2047-52. [PMID: 12087140]
33. Van Lente F, McErlean ES, DeLuca SA, Peacock WF, Rao JS, Nissen SE. Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study. J Am Coll Cardiol. 1999;33:471-8. [PMID: 9973028]
34. Apple FS, Pearce LA, Doyle PJ, Otto AP, Murakami MM. Cardiac troponin risk stratification based on 99th percentile reference cutoffs in patients with ischemic symptoms suggestive of acute coronary syndrome: influence of estimated glomerular filtration rates. Am J Clin Pathol. 2007;127:598-603. [PMID: 17369136]
35. Kontos MC, Garg R, Anderson FP, Tatum JL, Ornato JP, Jesse RL. Outcomes in patients admitted for chest pain with renal failure and troponin I elevations. Am Heart J. 2005;150:674-80. [PMID: 16209963]
36. Acharji S, Baber U, Mehran R, Fahy M, Kirtane AJ, Lansky AJ, et al. Prognostic significance of elevated baseline troponin in patients with acute coronary syndromes and chronic kidney disease treated with different antithrombotic regimens: a substudy from the ACUITY trial. Circ Cardiovasc Interv. 2012;5: 157-65. [PMID: 22354934] doi:10.1161/CIRCINTERVENTIONS.111 .963876
37. Han JH, Lindsell CJ, Ryan RJ, Gibler WB. Changes in cardiac troponin T measurements are associated with adverse cardiac events in patients with chronic kidney disease. Am J Emerg Med. 2005;23:468-73. [PMID: 16032613]
38. Wayand D, Baum H, Schätzle G, Schärf J, Neumeier D. Cardiac troponin T and I in end-stage renal failure. Clin Chem. 2000;46:1345-50. [PMID: 10973864]
39. Gruberg L, Fuchs S, Waksman R, Pichard AD, Kent KM, Laird JR, et al. Prognostic value of cardiac troponin I elevation after percutaneous coronary intervention in patients with chronic renal insufficiency: a 12-month outcome analysis. Catheter Cardiovasc Interv. 2002;55:174-9. [PMID: 11835642]
40. Bueti J, Krahn J, Karpinski M, Bohm C, Fine A, Rigatto C; Manitoba Renal Research Group. Troponin I testing in dialysis patients presenting to the emergency room: does troponin I predict the 30-day outcome? Nephron Clin Pract. 2006;103:c129-36. [PMID: 16636580]
41. Kontos MC, Garg R, Anderson FP, Tatum JL, Ornato JP, Jesse RL. Predictive power of ejection fraction and renal failure in patients admitted for chest pain without ST elevation in the troponin era. Am Heart J. 2005;150:666-73. [PMID: 16209962]
42. Kontos MC, Jamal SM, Ornato JP, Tatum JL, Jesse RL, Anderson FP. Comparison of the Modification of Diet in Renal Disease and the Cockcroft- Gault equations for predicting mortality in patients admitted for exclusion of myocardial ischemia. Am J Cardiol. 2008;102:140-5. [PMID: 18602510] doi:10.1016/j.amjcard.2008.03.023
43. Javed U, Aftab W, Ambrose JA, Wessel RJ, Mouanoutoua M, Huang G, et al. Frequency of elevated troponin I and diagnosis of acute myocardial infarction. Am J Cardiol. 2009;104:9-13. [PMID: 19576313] doi:10.1016/j .amjcard.2009.03.003
44. Ng SM, Krishnaswamy P, Morrisey R, Clopton P, Fitzgerald R, Maisel AS. Mitigation of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers. Am J Cardiol. 2001;87:994-9. [PMID: 11305993]
45. Palamalai V, Murakami MM, Apple FS. Diagnostic performance of four point of care cardiac troponin I assays to rule in and rule out acute myocardial infarction. Clin Biochem. 2013;46:1631-5. [PMID: 23850852] doi:10.1016/ j.clinbiochem.2013.06.026
46. Dohi T, Kasai T, Miyauchi K, Takasu K, Kajimoto K, Kubota N, et al. Prognostic impact of chronic kidney disease on 10-year clinical outcomes among patients with acute coronary syndrome. J Cardiol. 2012;60:438-42. [PMID: 23063662] doi:10.1016/j.jjcc.2012.08.007